Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Sell
5,875
-480
-8% -$11K 0.01% 346
2026
Q1
$140K Sell
6,355
-490
-7% -$8.53K 0.01% 321
2025
Q4
$80.7K Hold
6,845
0.01% 360
2025
Q3
$108K Sell
6,845
-610
-8% -$8.85K 0.01% 332
2025
Q2
$85.4K Buy
7,455
+85
+1% +$958 0.01% 341
2025
Q1
$99.7K Buy
7,370
+510
+7% +$8.47K 0.01% 315
2024
Q4
$116K Hold
6,860
0.01% 296
2024
Q3
$139K Buy
6,860
+2,851
+71% +$58.3K 0.02% 288
2024
Q2
$90.5K Buy
4,009
+9
+0.2% +$236 0.01% 319
2024
Q1
$105K Buy
4,000
+2,042
+104% +$58.2K 0.01% 304
2023
Q4
$61.8K Buy
+1,958
New +$53.1K 0.01% 338
2022
Q2
Sell
-31,773
Closed -$1M 190
2022
Q1
$1M Buy
+31,773
New +$994K 0.16% 116

Other funds holding CC

BFSG LLC's CC Position: Q2 2026 in Review

BFSG LLC reduced its Chemours (CC) stake by 7.6% in Q2 2026, selling an estimated $11K and leaving 5,875 shares worth $121K. The position accounts for 0.01% of the portfolio, ranked #346.

BFSG LLC first reported a position in CC in Q1 2022 and has held it in 12 quarters since. The position peaked at $1M in Q1 2022. 71 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • BFSG LLC held 5,875 shares of Chemours worth $121K as of Q2 2026.
  • BFSG LLC sold 480 Chemours shares in Q2 2026, an estimated $11K.
  • Chemours made up 0.01% of BFSG LLC's portfolio in Q2 2026, its #346 holding.
  • BFSG LLC first reported a position in Chemours in Q1 2022 and has held it in 12 quarters since.
  • BFSG LLC's Chemours position peaked at $1M in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.